P-30 Switch from ibalizumab to lenacapavir in a salvage therapy for a patient with multidrug-resistant HIV infection
Salvatore Martini(University of Campania "Luigi Vanvitelli"), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Adriana Raddi(Ospedale di Belcolle), Raffaele Palladino(Federico II University Hospital), Nunzia Cuomo(Federico II University Hospital), Aniello Russo(Harvard University), Mariantonietta Pisaturo(University of Antwerp)
Cited by 0
Related Papers
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Anticoagulant treatment in COVID-19: a narrative review
|Journal of Thrombosis and Thrombolysis|2020|111
Italy's health performance, 1990–2017: findings from the Global Burden of Disease Study 2017
|The Lancet Public Health|2019|96
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
|Journal of Hepatology|2023|94